Ljubimova Julia Y, Ramesh Arshia, Israel Liron L, Holler Eggehard
Terasaki Institute for Biomedical Innovation (TIBI), 1018 Westwood Blvd, Los Angeles, CA 90024, USA.
University of California, Los Angeles, CA 90024, USA.
Nanomaterials (Basel). 2021 Nov 8;11(11):2996. doi: 10.3390/nano11112996.
Research has increasingly focused on the delivery of high, often excessive amounts of drugs, neglecting negative aspects of the carrier's physical preconditions and biocompatibility. Among them, little attention has been paid to "small but beautiful" design of vehicle and multiple cargo to achieve effortless targeted delivery into deep tissue. The design of small biopolymers for deep tissue targeted delivery of multiple imaging agents and therapeutics (mini-nano carriers) emphasizes linear flexible polymer platforms with a hydrodynamic diameter of 4 nm to 10 nm, geometrically favoring dynamic juxtaposition of ligands to host receptors, and economic drug content. Platforms of biodegradable, non-toxic poly(β-l-malic acid) of this size carrying multiple chemically bound, optionally nature-derived or synthetic affinity peptides and drugs for a variety of purposes are described in this review with specific examples. The size, shape, and multiple attachments to membrane sites accelerate vascular escape and fast blood clearance, as well as the increase in medical treatment and contrasts for tissue imaging. High affinity antibodies routinely considered for targeting, such as the brain through the blood-brain barrier (BBB), are replaced by moderate affinity binding peptides (vectors), which penetrate at high influxes not achievable by antibodies.
研究越来越多地集中在大量(往往是过量)药物的递送,而忽视了载体的物理前提条件和生物相容性的负面因素。其中,对于能够轻松实现向深部组织靶向递送的“小而美”的载体和多种药物设计关注甚少。用于多种成像剂和治疗剂深部组织靶向递送的小型生物聚合物(微型纳米载体)设计强调流体动力学直径为4纳米至10纳米的线性柔性聚合物平台,在几何形状上有利于配体与宿主受体的动态并置,以及经济的药物含量。本文通过具体实例介绍了这种尺寸的可生物降解、无毒的聚(β-L-苹果酸)平台,其携带多种化学结合的、任选天然来源或合成的亲和肽以及用于各种目的的药物。其尺寸、形状以及与膜位点的多种连接促进了血管逃逸和快速血液清除,以及医疗效果的提升和组织成像对比度的增加。通常用于靶向的高亲和力抗体,如穿过血脑屏障(BBB)靶向脑部,被中等亲和力的结合肽(载体)所取代,这些肽以抗体无法达到的高流入量穿透。